GSA Capital Partners LLP trimmed its holdings in Orthofix International N.V. (NASDAQ:OFIX) by 59.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,321 shares of the medical device company’s stock after selling 46,188 shares during the quarter. GSA Capital Partners LLP owned about 0.17% of Orthofix International N.V. worth $1,456,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Arizona State Retirement System grew its holdings in Orthofix International N.V. by 1.1% in the 2nd quarter. Arizona State Retirement System now owns 9,400 shares of the medical device company’s stock worth $437,000 after buying an additional 100 shares in the last quarter. Systematic Financial Management LP grew its holdings in Orthofix International N.V. by 0.6% in the 1st quarter. Systematic Financial Management LP now owns 44,310 shares of the medical device company’s stock worth $1,690,000 after buying an additional 260 shares in the last quarter. Victory Capital Management Inc. grew its holdings in Orthofix International N.V. by 1.2% in the 2nd quarter. Victory Capital Management Inc. now owns 32,089 shares of the medical device company’s stock worth $1,491,000 after buying an additional 365 shares in the last quarter. AJO LP grew its holdings in Orthofix International N.V. by 0.4% in the 2nd quarter. AJO LP now owns 169,162 shares of the medical device company’s stock worth $7,863,000 after buying an additional 702 shares in the last quarter. Finally, American International Group Inc. grew its holdings in Orthofix International N.V. by 7.1% in the 1st quarter. American International Group Inc. now owns 10,783 shares of the medical device company’s stock worth $411,000 after buying an additional 717 shares in the last quarter. 94.40% of the stock is owned by institutional investors and hedge funds.

In related news, CFO Rice Doug sold 7,353 shares of the firm’s stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $49.46, for a total value of $363,679.38. Following the completion of the sale, the chief financial officer now owns 44,743 shares of the company’s stock, valued at $2,212,988.78. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Brad Mason sold 2,733 shares of the firm’s stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $48.10, for a total transaction of $131,457.30. Following the completion of the sale, the chief executive officer now directly owns 188,053 shares of the company’s stock, valued at approximately $9,045,349.30. The disclosure for this sale can be found here. In the last three months, insiders sold 23,406 shares of company stock valued at $1,138,531. 5.60% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/09/25/orthofix-international-n-v-ofix-position-cut-by-gsa-capital-partners-llp.html.

Shares of Orthofix International N.V. (NASDAQ OFIX) opened at 47.85 on Monday. The firm has a market capitalization of $869.43 million, a P/E ratio of 112.06 and a beta of 0.22. The firm has a 50-day moving average price of $47.80 and a 200-day moving average price of $43.18. Orthofix International N.V. has a 52-week low of $32.51 and a 52-week high of $50.40.

Orthofix International N.V. (NASDAQ:OFIX) last issued its quarterly earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. The business had revenue of $108.90 million during the quarter, compared to analyst estimates of $102.94 million. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. Orthofix International N.V.’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.41 earnings per share. On average, equities research analysts anticipate that Orthofix International N.V. will post $1.56 EPS for the current year.

A number of equities research analysts have weighed in on the company. Langenberg & Company restated a “buy” rating and issued a $53.25 target price on shares of Orthofix International N.V. in a research report on Wednesday, June 14th. Zacks Investment Research upgraded Orthofix International N.V. from a “sell” rating to a “hold” rating in a research report on Thursday, July 6th. BTIG Research assumed coverage on Orthofix International N.V. in a research report on Wednesday, June 21st. They issued a “buy” rating and a $52.00 target price for the company. Ladenburg Thalmann Financial Services assumed coverage on Orthofix International N.V. in a research report on Wednesday, June 14th. They issued a “buy” rating and a $53.25 target price for the company. Finally, TheStreet upgraded Orthofix International N.V. from a “c+” rating to a “b-” rating in a research report on Tuesday, August 8th. Seven equities research analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and an average price target of $52.75.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

Institutional Ownership by Quarter for Orthofix International N.V. (NASDAQ:OFIX)

Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.